We decided to study the effects of type I interferon α 2 (IFNa2; IFN hereafter) on human HAP1 cells, a chronic myeloid leukaemia (CML)-derived cell line, in the presence or absence of the USP18 gene. This evidence concerns the gene IFNA2 and chronic myelogenous leukemia, BCR-ABL1 positive.